Personal information

Other IDs

ResearcherID: KYQ-2389-2024

Keywords

Alzheimer's disease, Apolipoprotein E, ApoE, glycosylation

Countries

Spain

Biography

I'm a PhD student in the Instituto de Neurociencias, Universidad Miguel Hernández. My current research consists in the characterization of Apolipoprotein E, the major risk factor for Alzheimer's Disease. The aim is to describe the glycosylation patterns of the molecule across the different stages of the pathology, and to determine which factors play key roles in this process.

Activities

Collapse all

Employment (1)

Universidad Miguel Hernandez de Elche - Campus San Juan de Alicante: San Juan, ES

2019-09-01 to present | PhD Researcher (Instituto de Neurociencias)
Employment
Source: Self-asserted source
Matthew Paul Lennol

Education and qualifications (2)

Universidad Autónoma de Madrid: Madrid, Madrid, ES

2016-09-01 to 2018-09-15 | Máster en Neurociencias (Facultad de Medicina)
Education
Source: Self-asserted source
Matthew Paul Lennol

Universitat de València: Valencia, Comunitat Valenciana, ES

2012-09-01 to 2016-06-01 | Grado en Psicología (Facultad de Psicología)
Education
Source: Self-asserted source
Matthew Paul Lennol

Works (6)

Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.

International journal of molecular sciences
2023-02-01 | Journal article
DOI: 10.3390/ijms24032715
PMID: 36769057
PMC: PMC9917569
Contributors: Lennol MP; Nicholas Ashton; Oscar Moreno-Perez; María-Salud García-Ayllón; Jose-Manuel Ramos-Rincon; Mariano Andrés; JOSE-MANUEL LEON-RAMIREZ; Boix V; Gil J; Blennow K et al.
Source: Self-asserted source
Matthew Paul Lennol
grade
Preferred source (of 2)‎

Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients.

Alzheimer's research & therapy
2022-11-02 | Journal article
DOI: 10.1186/s13195-022-01108-2
PMID: 36324176
PMC: PMC9628034
Contributors: Lennol MP; Sánchez-Domínguez I; Inmaculada Cuchillo Ibáñez; Camporesi E; Brinkmalm G; Alcolea D; Fortea J; Lleó A; Guadalupe Soria; Aguado F et al.
Source: Self-asserted source
Matthew Paul Lennol
grade
Preferred source (of 2)‎

Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy.

Frontiers in immunology
2022-10-12 | Journal article
DOI: 10.3389/fimmu.2022.1001951
PMID: 36311758
PMC: PMC9597869
Contributors: Lennol MP; María-Salud García-Ayllón; MARIANO ESTEBAN; García-Arriaza J; Sáez-Valero J
Source: Self-asserted source
Matthew Paul Lennol
grade
Preferred source (of 2)‎

Altered Balance of Reelin Proteolytic Fragments in the Cerebrospinal Fluid of Alzheimer's Disease Patients.

International journal of molecular sciences
2022-07-07 | Journal article
DOI: 10.3390/ijms23147522
PMID: 35886870
PMC: PMC9318932
Contributors: Lopez-Font I; Lennol MP; Iborra-Lazaro G; Zetterberg H; Blennow K; Javier Sáez-Valero
Source: Self-asserted source
Matthew Paul Lennol
grade
Preferred source (of 2)‎

The apolipoprotein receptor LRP3 compromises APP levels.

Alzheimer's research & therapy
2021-11-02 | Journal article
DOI: 10.1186/s13195-021-00921-5
PMID: 34727970
PMC: PMC8565065
Source: Self-asserted source
Matthew Paul Lennol
grade
Preferred source (of 2)‎

Amyloid-β1-40 differentially stimulates proliferation, activation of oxidative stress and inflammatory responses in male and female hippocampal astrocyte cultures.

Mechanisms of ageing and development
2021-02-17 | Journal article
DOI: 10.1016/j.mad.2021.111462
PMID: 33609535
Source: Self-asserted source
Matthew Paul Lennol
grade
Preferred source (of 2)‎

Peer review (7 reviews for 3 publications/grants)

Review activity for Journal of autoimmunity. (1)
Review activity for Neurobiology of aging. (1)
Review activity for PloS one. (5)
How many people are using ORCID?